Federal Data HubHRSA 340B · JSON

Rush Hemophilia and Thrombophilia Center

340B ID HM606121

ParticipatingHemophilia Treatment Center

Rush Hemophilia and Thrombophilia Center is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in CHICAGO, IL. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 12 contract-pharmacy arrangement(s) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (12)

PharmacyLocationBeginTerminatedPharmacy ID
ACCREDO HEALTH GROUP INCELMHURST, IL2018-01-017218
ACCREDO HEALTH GROUP INCWARRENDALE, PA2017-10-0123041
ACCREDO HEALTH GROUP INCMEMPHIS, TN2023-01-0145979
ACCREDO HEALTH GROUP, INC.LENEXA, KS2018-01-0162883
HEALTH DELIVERY MANAGEMENT LLCCHICAGO, IL2019-07-01118316
HEALTH DELIVERY MANAGEMENT, L.L.C.CHICAGO, IL2019-07-017184
OPTUM INFUSION SERVICES 305, LLCLENEXA, KS2025-07-0162882
OPTUM INFUSION SERVICES 501, INC.BUFFALO GROVE, IL2025-07-01133071
OPTUM INFUSION SERVICES 550, LLCCINCINNATI, OH2025-07-0150817
OPTUM PHARMACY 701, LLCFLINT, MI2025-07-01132743
PROFESSIONAL OFFICE BUILDINGCHICAGO, IL2004-08-017183
THE BLEEDING AND CLOTTING DISORDERS INSTPEORIA, IL2023-01-0160608

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.